Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-066995
Filing Date
2008-12-12
Accepted
2008-12-12 06:03:37
Documents
2
Period of Report
2008-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd226296.html 4  
1 FORM 4 rrd226296.xml 4 4575
2 POWER OF ATTORNEY rrd202653_228445.htm EX-24. 2337
  Complete submission text file 0001181431-08-066995.txt   8953
Mailing Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705
Business Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705 (510) 281-7700
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO RIVER GROUP HOLDINGS, LLC. 689 FIFTH AVENUE NEW YORK NY 10022
Business Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019 212-871-7900
TANEN DAVID M (Reporting) CIK: 0001170542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 081244804